Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Nasogastric Tubes Market by Product (Levin Catheter, Dobhoff Tube, Sengstaken-Blakemore Tube, Others), by Age group (Pediatrics, Adults) and by End users (Hospitals, Paediatric and Neonatal Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A10901

Pages: NA

Charts: NA

Tables: NA

Nasogastric Tubes Market Outlook - 2027

Proper nutritional uptake plays a pivotal in well-being and maintaining an optimal level of health along with prevention of various health conditions and diseases. The nasogastric (NG) tubes are commonly used for providing enteral nutrition and medications for infants, adults and elderly patients as well who have trouble consuming and swallowing food and medicine. Preterm born infants and sick babies face restrictions in supply of essential nutrients and calories. The nasogastric tubes ensure the delivery of essential nutritional elements as well as medications in these situations. The NG tube that is directed through the nasal cavity and bypasses the nasopharynx and esophagus to reach the stomach. It is generally composed of rubber or plastic and is attributed with flexibility and bidirectional potential. It also utilized in removal of unwanted contents present in the stomach, deplete gastric substances, decompress the stomach, or in removal of harmful semi-solids and fluid, such as poison, from the stomach. The NG tube provides a passage to GI tract which aids in the treatment of bowel reconstruction and gastric immobility.

COVID – 19 scenario analysis: 

  • The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses
  • Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth
  • Over 4 million people affected globally, with 300 thousand losing their lives due to SARS-CoV-2
  • Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers
  • Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to enteral nutrition has been reduced and this segment have to face negligence subsequently causing negative impact on nasogastric tubes market

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The prime factors driving the growth of nasogastric tubes market include increasing number of preterm births and rising demand for enteral nutrition. Premature born infants have scarce supply of essential nutrients and calories for sustaining metabolic activities; as a result, it becomes increasingly important to provide them with sufficient levels of nutritional intake and maintain energy levels. Thus, the nasogastric tubes offer proper nourishment to premature born infants which will surge the demand for these tubes in the market having a positive impact on the industry growth in coming years.

Exponentially rising geriatric population coupled with growing prevalence of chronic ailments including diabetes, cancer, cardiovascular diseases, respiratory and gastrointestinal diseases resulting into increase of patient pools are the key factors driving the growth of nasogastric tubes market. The growing incidences of hospitalization among both pediatric and elderly populace will offer lucrative avenues for the business growth as nasogastric tubes are increasingly required in hospitals for facilitating enteral feeding, providing medicinal support and gastric decompression. Additionally, changing trends pertaining shift to enteral from parenteral feeding and rising consciousness among populace regarding enteral feeding will foster the industry growth in the near future.

However, restrains including occurrence of skin irritation and infections due to nasogastric procedures caused by improper sterilization, tube dislocation can impede the market growth. Furthermore, high intensity of suction of these tubes during removal of gastric wastes can potentially damage gastric mucosa and result into bleeding would be another hampering factor for the nasogastric tubes market.

Increasing incidences of premature births to amplify the market growth

The ever rising high birth rate in developing and developed countries, rising prevalence of premature births will surge the demand for nasogastric tubes in the market. As per the UNICEF (United Nations International Children's Emergency Fund) studies, it was seen that approximately 2.5 million children died in 2017, in the first month after their birth. WHO data reveal that one premature birth take place every 10 babies born globally, accounting for around 15 million pre-mature births occur globally. Premature born babies are prone to problems including simultaneous ventilation, oral aversion and neurological disorders like cerebral palsy limiting the food consumption would aid in the development of the nasogastric tubes market.   

Rise in geriatric population and life expectancy to fuel the growth

Rising geriatric population, increasing incidences of various diseases owing to rising age creating a patient pool and demand for nutritional support are the factors contributing to the market growth.

The rising birthrate, advancements in the medical field and reduction in the cost of treatments along with use of various multi-faceted therapies against number of chronic diseases has increased the life expectancy has led to the global population is aging rapidly. As per the report, ‘World Ageing Population, 2019’ the older population, i.e., people belonging to age group 65 and above accounted for approximately 702.9 million cases of GI disorders all around the world and it is expected to hit 1500 million mark. The UN statistics also highlight the growth of elderly population aged 60 years and above is projected to reach 2.0 billion by 2050 from current figures that is 960 million in 2017. Therefore, increasing geriatric population would contribute to rise in the market for nasogastric tubes.

Key benefits of the report:

  • This study presents the analytical depiction of the global nasogastric tubes industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global nasogastric tubes market share.
  • The current market is quantitatively analysed to highlight the nasogastric tubes market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global nasogastric tubes market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Nasogastric tubes market research report:

  • What are the leading market players active in the nasogastric tubes market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Key Market Segments

  • By Product
    • Levin Catheter
    • Dobhoff Tube
    • Sengstaken-Blakemore Tube
    • Others
  • By Age group
    • Pediatrics
    • Adults
  • By End users
    • Hospitals
    • Paediatric and Neonatal Clinics
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA


Key Market Players

  • Poly Medicure Limited
  • Bicakcilar A.S.
  • C.R. Bard Medical,
  • Andersen Products Inc.
  • Degania Silicone Ltd.,
  • SecurMed
  • Rontis Medical
  • Pacific Hospital Supply Co. Ltd.,
  • Cardinal Health,
  • Guangdong Baihe Medical Technology,
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: NASOGASTRIC TUBES MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Levin Catheter

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Dobhoff Tube

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Sengstaken-Blakemore Tube

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Others

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: NASOGASTRIC TUBES MARKET, BY AGE GROUP

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Age Group

    • 5.2. Pediatrics

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Adults

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: NASOGASTRIC TUBES MARKET, BY END USERS

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End Users

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Paediatric And Neonatal Clinics

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Others

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: NASOGASTRIC TUBES MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Age Group

      • 7.2.4. Market Size and Forecast, By End Users

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Nasogastric Tubes Market

        • 7.2.6.1. Market Size and Forecast, By Product
        • 7.2.6.2. Market Size and Forecast, By Age Group
        • 7.2.6.3. Market Size and Forecast, By End Users
      • 7.2.7. Canada Nasogastric Tubes Market

        • 7.2.7.1. Market Size and Forecast, By Product
        • 7.2.7.2. Market Size and Forecast, By Age Group
        • 7.2.7.3. Market Size and Forecast, By End Users
      • 7.2.8. Mexico Nasogastric Tubes Market

        • 7.2.8.1. Market Size and Forecast, By Product
        • 7.2.8.2. Market Size and Forecast, By Age Group
        • 7.2.8.3. Market Size and Forecast, By End Users
    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Age Group

      • 7.3.4. Market Size and Forecast, By End Users

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Nasogastric Tubes Market

        • 7.3.6.1. Market Size and Forecast, By Product
        • 7.3.6.2. Market Size and Forecast, By Age Group
        • 7.3.6.3. Market Size and Forecast, By End Users
      • 7.3.7. Germany Nasogastric Tubes Market

        • 7.3.7.1. Market Size and Forecast, By Product
        • 7.3.7.2. Market Size and Forecast, By Age Group
        • 7.3.7.3. Market Size and Forecast, By End Users
      • 7.3.8. Italy Nasogastric Tubes Market

        • 7.3.8.1. Market Size and Forecast, By Product
        • 7.3.8.2. Market Size and Forecast, By Age Group
        • 7.3.8.3. Market Size and Forecast, By End Users
      • 7.3.9. Spain Nasogastric Tubes Market

        • 7.3.9.1. Market Size and Forecast, By Product
        • 7.3.9.2. Market Size and Forecast, By Age Group
        • 7.3.9.3. Market Size and Forecast, By End Users
      • 7.3.10. UK Nasogastric Tubes Market

        • 7.3.10.1. Market Size and Forecast, By Product
        • 7.3.10.2. Market Size and Forecast, By Age Group
        • 7.3.10.3. Market Size and Forecast, By End Users
      • 7.3.11. Russia Nasogastric Tubes Market

        • 7.3.11.1. Market Size and Forecast, By Product
        • 7.3.11.2. Market Size and Forecast, By Age Group
        • 7.3.11.3. Market Size and Forecast, By End Users
      • 7.3.12. Rest Of Europe Nasogastric Tubes Market

        • 7.3.12.1. Market Size and Forecast, By Product
        • 7.3.12.2. Market Size and Forecast, By Age Group
        • 7.3.12.3. Market Size and Forecast, By End Users
    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Age Group

      • 7.4.4. Market Size and Forecast, By End Users

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Nasogastric Tubes Market

        • 7.4.6.1. Market Size and Forecast, By Product
        • 7.4.6.2. Market Size and Forecast, By Age Group
        • 7.4.6.3. Market Size and Forecast, By End Users
      • 7.4.7. Japan Nasogastric Tubes Market

        • 7.4.7.1. Market Size and Forecast, By Product
        • 7.4.7.2. Market Size and Forecast, By Age Group
        • 7.4.7.3. Market Size and Forecast, By End Users
      • 7.4.8. India Nasogastric Tubes Market

        • 7.4.8.1. Market Size and Forecast, By Product
        • 7.4.8.2. Market Size and Forecast, By Age Group
        • 7.4.8.3. Market Size and Forecast, By End Users
      • 7.4.9. South Korea Nasogastric Tubes Market

        • 7.4.9.1. Market Size and Forecast, By Product
        • 7.4.9.2. Market Size and Forecast, By Age Group
        • 7.4.9.3. Market Size and Forecast, By End Users
      • 7.4.10. Australia Nasogastric Tubes Market

        • 7.4.10.1. Market Size and Forecast, By Product
        • 7.4.10.2. Market Size and Forecast, By Age Group
        • 7.4.10.3. Market Size and Forecast, By End Users
      • 7.4.11. Thailand Nasogastric Tubes Market

        • 7.4.11.1. Market Size and Forecast, By Product
        • 7.4.11.2. Market Size and Forecast, By Age Group
        • 7.4.11.3. Market Size and Forecast, By End Users
      • 7.4.12. Malaysia Nasogastric Tubes Market

        • 7.4.12.1. Market Size and Forecast, By Product
        • 7.4.12.2. Market Size and Forecast, By Age Group
        • 7.4.12.3. Market Size and Forecast, By End Users
      • 7.4.13. Indonesia Nasogastric Tubes Market

        • 7.4.13.1. Market Size and Forecast, By Product
        • 7.4.13.2. Market Size and Forecast, By Age Group
        • 7.4.13.3. Market Size and Forecast, By End Users
      • 7.4.14. Rest of Asia Pacific Nasogastric Tubes Market

        • 7.4.14.1. Market Size and Forecast, By Product
        • 7.4.14.2. Market Size and Forecast, By Age Group
        • 7.4.14.3. Market Size and Forecast, By End Users
    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Age Group

      • 7.5.4. Market Size and Forecast, By End Users

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Nasogastric Tubes Market

        • 7.5.6.1. Market Size and Forecast, By Product
        • 7.5.6.2. Market Size and Forecast, By Age Group
        • 7.5.6.3. Market Size and Forecast, By End Users
      • 7.5.7. South Africa Nasogastric Tubes Market

        • 7.5.7.1. Market Size and Forecast, By Product
        • 7.5.7.2. Market Size and Forecast, By Age Group
        • 7.5.7.3. Market Size and Forecast, By End Users
      • 7.5.8. Saudi Arabia Nasogastric Tubes Market

        • 7.5.8.1. Market Size and Forecast, By Product
        • 7.5.8.2. Market Size and Forecast, By Age Group
        • 7.5.8.3. Market Size and Forecast, By End Users
      • 7.5.9. UAE Nasogastric Tubes Market

        • 7.5.9.1. Market Size and Forecast, By Product
        • 7.5.9.2. Market Size and Forecast, By Age Group
        • 7.5.9.3. Market Size and Forecast, By End Users
      • 7.5.10. Argentina Nasogastric Tubes Market

        • 7.5.10.1. Market Size and Forecast, By Product
        • 7.5.10.2. Market Size and Forecast, By Age Group
        • 7.5.10.3. Market Size and Forecast, By End Users
      • 7.5.11. Rest of LAMEA Nasogastric Tubes Market

        • 7.5.11.1. Market Size and Forecast, By Product
        • 7.5.11.2. Market Size and Forecast, By Age Group
        • 7.5.11.3. Market Size and Forecast, By End Users
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Andersen Products Inc.

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Bicakcilar A.S.

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. C.R. Bard Medical,

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Degania Silicone Ltd.,

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Pacific Hospital Supply Co. Ltd.,

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Cardinal Health,

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Guangdong Baihe Medical Technology,

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Rontis Medical

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Poly Medicure Limited

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. SecurMed

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL NASOGASTRIC TUBES MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL NASOGASTRIC TUBES MARKET FOR LEVIN CATHETER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL NASOGASTRIC TUBES MARKET FOR DOBHOFF TUBE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL NASOGASTRIC TUBES MARKET FOR SENGSTAKEN-BLAKEMORE TUBE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL NASOGASTRIC TUBES MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL NASOGASTRIC TUBES MARKET, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL NASOGASTRIC TUBES MARKET FOR PEDIATRICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL NASOGASTRIC TUBES MARKET FOR ADULTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL NASOGASTRIC TUBES MARKET, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL NASOGASTRIC TUBES MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL NASOGASTRIC TUBES MARKET FOR PAEDIATRIC AND NEONATAL CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL NASOGASTRIC TUBES MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL NASOGASTRIC TUBES MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. NORTH AMERICA NASOGASTRIC TUBES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 18. U.S. NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 19. U.S. NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 20. U.S. NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 21. CANADA NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 22. CANADA NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 23. CANADA NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 24. MEXICO NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 25. MEXICO NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 26. MEXICO NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 27. EUROPE NASOGASTRIC TUBES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 28. EUROPE NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 29. EUROPE NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 31. FRANCE NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 32. FRANCE NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 33. FRANCE NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 34. GERMANY NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 35. GERMANY NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 36. GERMANY NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 37. ITALY NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 38. ITALY NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 39. ITALY NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 40. SPAIN NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 41. SPAIN NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 42. SPAIN NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 43. UK NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 44. UK NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 45. UK NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 46. RUSSIA NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 47. RUSSIA NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 48. RUSSIA NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 49. REST OF EUROPE NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 50. REST OF EUROPE NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 51. REST OF EUROPE NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 52. ASIA-PACIFIC NASOGASTRIC TUBES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 53. ASIA-PACIFIC NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 54. ASIA-PACIFIC NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 56. CHINA NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 57. CHINA NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 58. CHINA NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 59. JAPAN NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 60. JAPAN NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 61. JAPAN NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 62. INDIA NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 63. INDIA NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 64. INDIA NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 65. SOUTH KOREA NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 66. SOUTH KOREA NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH KOREA NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 68. AUSTRALIA NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 69. AUSTRALIA NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 70. AUSTRALIA NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 71. THAILAND NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 72. THAILAND NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 73. THAILAND NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 74. MALAYSIA NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 75. MALAYSIA NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 76. MALAYSIA NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 77. INDONESIA NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 78. INDONESIA NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 79. INDONESIA NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 80. REST OF ASIA PACIFIC NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 81. REST OF ASIA PACIFIC NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 83. LAMEA NASOGASTRIC TUBES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 84. LAMEA NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 85. LAMEA NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 87. BRAZIL NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 88. BRAZIL NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 89. BRAZIL NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 90. SOUTH AFRICA NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 91. SOUTH AFRICA NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 92. SOUTH AFRICA NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 93. SAUDI ARABIA NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 94. SAUDI ARABIA NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 95. SAUDI ARABIA NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 96. UAE NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 97. UAE NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 98. UAE NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 99. ARGENTINA NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 100. ARGENTINA NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 101. ARGENTINA NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 102. REST OF LAMEA NASOGASTRIC TUBES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 103. REST OF LAMEA NASOGASTRIC TUBES, BY AGE GROUP, 2025-2033 ($MILLION)
  • TABLE 104. REST OF LAMEA NASOGASTRIC TUBES, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 105. ANDERSEN PRODUCTS INC.: KEY EXECUTIVES
  • TABLE 106. ANDERSEN PRODUCTS INC.: COMPANY SNAPSHOT
  • TABLE 107. ANDERSEN PRODUCTS INC.: OPERATING SEGMENTS
  • TABLE 108. ANDERSEN PRODUCTS INC.: PRODUCT PORTFOLIO
  • TABLE 109. ANDERSEN PRODUCTS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 110. BICAKCILAR A.S.: KEY EXECUTIVES
  • TABLE 111. BICAKCILAR A.S.: COMPANY SNAPSHOT
  • TABLE 112. BICAKCILAR A.S.: OPERATING SEGMENTS
  • TABLE 113. BICAKCILAR A.S.: PRODUCT PORTFOLIO
  • TABLE 114. BICAKCILAR A.S.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 115. C.R. BARD MEDICAL,: KEY EXECUTIVES
  • TABLE 116. C.R. BARD MEDICAL,: COMPANY SNAPSHOT
  • TABLE 117. C.R. BARD MEDICAL,: OPERATING SEGMENTS
  • TABLE 118. C.R. BARD MEDICAL,: PRODUCT PORTFOLIO
  • TABLE 119. C.R. BARD MEDICAL,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 120. DEGANIA SILICONE LTD.,: KEY EXECUTIVES
  • TABLE 121. DEGANIA SILICONE LTD.,: COMPANY SNAPSHOT
  • TABLE 122. DEGANIA SILICONE LTD.,: OPERATING SEGMENTS
  • TABLE 123. DEGANIA SILICONE LTD.,: PRODUCT PORTFOLIO
  • TABLE 124. DEGANIA SILICONE LTD.,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 125. PACIFIC HOSPITAL SUPPLY CO. LTD.,: KEY EXECUTIVES
  • TABLE 126. PACIFIC HOSPITAL SUPPLY CO. LTD.,: COMPANY SNAPSHOT
  • TABLE 127. PACIFIC HOSPITAL SUPPLY CO. LTD.,: OPERATING SEGMENTS
  • TABLE 128. PACIFIC HOSPITAL SUPPLY CO. LTD.,: PRODUCT PORTFOLIO
  • TABLE 129. PACIFIC HOSPITAL SUPPLY CO. LTD.,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 130. CARDINAL HEALTH,: KEY EXECUTIVES
  • TABLE 131. CARDINAL HEALTH,: COMPANY SNAPSHOT
  • TABLE 132. CARDINAL HEALTH,: OPERATING SEGMENTS
  • TABLE 133. CARDINAL HEALTH,: PRODUCT PORTFOLIO
  • TABLE 134. CARDINAL HEALTH,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 135. GUANGDONG BAIHE MEDICAL TECHNOLOGY,: KEY EXECUTIVES
  • TABLE 136. GUANGDONG BAIHE MEDICAL TECHNOLOGY,: COMPANY SNAPSHOT
  • TABLE 137. GUANGDONG BAIHE MEDICAL TECHNOLOGY,: OPERATING SEGMENTS
  • TABLE 138. GUANGDONG BAIHE MEDICAL TECHNOLOGY,: PRODUCT PORTFOLIO
  • TABLE 139. GUANGDONG BAIHE MEDICAL TECHNOLOGY,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 140. RONTIS MEDICAL: KEY EXECUTIVES
  • TABLE 141. RONTIS MEDICAL: COMPANY SNAPSHOT
  • TABLE 142. RONTIS MEDICAL: OPERATING SEGMENTS
  • TABLE 143. RONTIS MEDICAL: PRODUCT PORTFOLIO
  • TABLE 144. RONTIS MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 145. POLY MEDICURE LIMITED: KEY EXECUTIVES
  • TABLE 146. POLY MEDICURE LIMITED: COMPANY SNAPSHOT
  • TABLE 147. POLY MEDICURE LIMITED: OPERATING SEGMENTS
  • TABLE 148. POLY MEDICURE LIMITED: PRODUCT PORTFOLIO
  • TABLE 149. POLY MEDICURE LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 150. SECURMED: KEY EXECUTIVES
  • TABLE 151. SECURMED: COMPANY SNAPSHOT
  • TABLE 152. SECURMED: OPERATING SEGMENTS
  • TABLE 153. SECURMED: PRODUCT PORTFOLIO
  • TABLE 154. SECURMED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL NASOGASTRIC TUBES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL NASOGASTRIC TUBES MARKET
  • FIGURE 3. SEGMENTATION NASOGASTRIC TUBES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN NASOGASTRIC TUBES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALNASOGASTRIC TUBES MARKET
  • FIGURE 11. NASOGASTRIC TUBES MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. NASOGASTRIC TUBES MARKET FOR LEVIN CATHETER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. NASOGASTRIC TUBES MARKET FOR DOBHOFF TUBE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. NASOGASTRIC TUBES MARKET FOR SENGSTAKEN-BLAKEMORE TUBE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. NASOGASTRIC TUBES MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. NASOGASTRIC TUBES MARKET SEGMENTATION, BY BY AGE GROUP
  • FIGURE 17. NASOGASTRIC TUBES MARKET FOR PEDIATRICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. NASOGASTRIC TUBES MARKET FOR ADULTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. NASOGASTRIC TUBES MARKET SEGMENTATION, BY BY END USERS
  • FIGURE 20. NASOGASTRIC TUBES MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. NASOGASTRIC TUBES MARKET FOR PAEDIATRIC AND NEONATAL CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. NASOGASTRIC TUBES MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 27. COMPETITIVE DASHBOARD
  • FIGURE 28. COMPETITIVE HEATMAP: NASOGASTRIC TUBES MARKET
  • FIGURE 29. TOP PLAYER POSITIONING, 2024
  • FIGURE 30. ANDERSEN PRODUCTS INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 31. ANDERSEN PRODUCTS INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 32. ANDERSEN PRODUCTS INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 33. BICAKCILAR A.S.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. BICAKCILAR A.S.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. BICAKCILAR A.S.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. C.R. BARD MEDICAL,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. C.R. BARD MEDICAL,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. C.R. BARD MEDICAL,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. DEGANIA SILICONE LTD.,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. DEGANIA SILICONE LTD.,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. DEGANIA SILICONE LTD.,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. PACIFIC HOSPITAL SUPPLY CO. LTD.,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. PACIFIC HOSPITAL SUPPLY CO. LTD.,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. PACIFIC HOSPITAL SUPPLY CO. LTD.,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. CARDINAL HEALTH,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. CARDINAL HEALTH,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. CARDINAL HEALTH,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. GUANGDONG BAIHE MEDICAL TECHNOLOGY,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. GUANGDONG BAIHE MEDICAL TECHNOLOGY,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. GUANGDONG BAIHE MEDICAL TECHNOLOGY,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. RONTIS MEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. RONTIS MEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. RONTIS MEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. POLY MEDICURE LIMITED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. POLY MEDICURE LIMITED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. POLY MEDICURE LIMITED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 57. SECURMED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 58. SECURMED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 59. SECURMED: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Nasogastric Tubes Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue